Skip to content

Effect of Eremostachys Laciniata suppository on post secarean section pain and distress

Effect of Eremostachys Laciniata suppository on post secarean section pain and distress triple blind controlled clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20150424021917N9
Enrollment
86
Registered
2018-10-31
Start date
2018-08-13
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain after cesarean section. Pelvic and perineal pain

Interventions

Intervention 1: The intervention group
will be receive Eremostachys rectal suppository (Chelledaghi herbal extract) every 8 hours to 3 doses. Intervention 2: The control group
will be receive receive diclofenac rectal suppository 50 mg every 8 hours to 3 doses.

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Women of childbearing age Gestational age 39 weeks full Body mass index (BMI) normal (25-19) The lack of pairs of adhesions based on the Calledapel ultrasound

Exclusion criteria

Exclusion criteria: Unwilling to participate in the study Having any underlying illness Having gastric ulcer Increase the duration of surgery for more than an hour High-risk pregnancies Damage to body tissues during cesarean section Emergency Cesarean section

Design outcomes

Primary

MeasureTime frame
Pain severity. Timepoint: Before intervention and after intervention (every 8 hours in the first 24 hours after cesarean section). Method of measurement: Visual Analog Scale (VAS).

Secondary

MeasureTime frame
Perceived distress score after cesarean section. Timepoint: 24 hours after cesarean section. Method of measurement: Symptom Distress Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSevil Hakimi

Tabriz University of Medical Sciences

hakimis@tbzmed.ac.ir+98 41 3475 3907

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026